风湿病学未满足需求:2019年靶向治疗会议报告
第21届国际靶向治疗年会汇集逾百名风湿病学、免疫学等领域专家,分5个疾病组讨论未满足的临床与转化研究需求。跨疾病主题包括创新临床试验设计、聚焦难治性疾病、考虑疾病内型和重叠炎症性疾病、了解发展中地区炎症疾病流行情况以及开发治愈性疗法。结论强调难治性疾病的新疗法和试验设计仍是风湿病学首要优先事项。
要点
- 跨疾病核心需求是创新临床试验设计并重点研究难治性疾病患者。
- 试验应考虑疾病内型及重叠炎症性疾病患者。
- 需了解发展中地区炎症疾病的患病率和发病率。
核心结论
- 难治性疾病的新疗法和试验设计仍是风湿病学最优先的未满足需求。
研究设计与样本
- 第21届国际靶向治疗年会汇集逾100名基础科学家和临床研究者,分5个疾病组(类风湿关节炎、银屑病关节炎、中轴脊柱关节炎、系统性红斑狼疮和其他系统性自身免疫风湿病)进行分组讨论,每组20-30名专家。
主要发现
- 跨所有疾病状态的主题包括创新临床试验设计、重点研究难治性疾病患者、考虑疾病内型和重叠炎症性疾病患者、了解发展中地区炎症疾病流行情况以及开发治愈性疗法。
临床怎么用
- 临床研究应优先纳入难治性疾病患者,试验设计需考虑疾病内型和重叠炎症性疾病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To detail the greatest areas of unmet scientific and clinical needs in rheumatology. METHODS: The 21st annual international Advances in Targeted Therapies meeting brought together more than 100 leading basic scientists and clinical researchers in rheumatology, immunology, epidemiology, molecular biology and other specialties. During the meeting, breakout sessions were convened, consisting of 5 disease-specific groups with 20-30 experts assigned to each group based on expertise. Specific groups included: rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, systemic lupus erythematosus and other systemic autoimmune rheumatic diseases. In each group, experts were asked to identify unmet clinical and translational research needs in general and then to prioritise and detail the most important specific needs within each disease area. RESULTS: Overarching themes across all disease states included the need to innovate clinical trial design with emphasis on studying patients with refractory disease, the development of trials that take into account disease endotypes and patients with overlapping inflammatory diseases, the need to better understand the prevalence and incidence of inflammatory diseases in developing regions of the world and ultimately to develop therapies that can cure inflammatory autoimmune diseases. CONCLUSIONS: Unmet needs for new therapies and trial designs, particularly for those with treatment refractory disease, remain a top priority in rheumatology.
引用
- Winthrop KL, Weinblatt ME, Bathon J, et al. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019. Ann Rheum Dis. 2019. PMID: 31662322. doi:10.1136/annrheumdis-2019-216151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。